ArticleScientific reports2026
The role of red blood cell distribution width in prognosis prediction among critically ill patients with obstructive sleep apnea: Insights from the MIMIC-IV database.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Obstructive sleep apnea (OSA) is prevalent in critically ill patients and associated with increased mortality. This study aimed to investigate the association between red blood cell distribution width (RDW) at admission and one-year mortality in critically ill OSA patients. A retrospective cohort study involving 1950 critically ill patients with OSA from the MIMIC-IV (v3.1) database. Kaplan-Meier survival analysis, multivariable Cox regression, and restricted cubic spline (RCS) analyses were performed to evaluate the association between RDW and all-cause mortality. Subgroup analyses were performed to assess the consistency of the RDW-mortality association and identify potential interaction effects. The incidence of mortality increased significantly across RDW quartiles (Q1: 4.6% vs. Q2: 12.1% vs. Q3: 18.4% vs. Q4: 34.7%, P < 0.001). Kaplan-Meier analysis demonstrated significantly higher 30-day and one-year all-cause mortality among patients in the higher RDW quartiles (log-rank P< 0.001). Multivariate Cox regression analysis revealed that RDW levels were independently correlated with one-year mortality after adjusting for multiple variables for both continuous (hazard ratio [HR] 1.15, 95% confidence interval [CI]: 1.10-1.20; P < 0.001) and categorical comparisons (Q4 vs. Q1: HR 4.42, 95% CI: 2.67-7.31; P< 0.001). RCS regression confirmed a significant positive relationship between RDW and the risk of short- or long-term mortality (P
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.